Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
376 - We have a PAAB-approved fax blast for pharmacists. Our marketing team wants to remove the product codes and prices and send the piece to physicians. This is the only change…would the revised fax blast need to go through PAAB-review? If it does not, is it ok to keep the PAAB logo on the piece?
-
Per the Submission Guidance document on our website at: http://www.paab.ca/resources/pdfs/code-revision/Guidance_on_Submission_Process.pdf The described change would require review (as would any removal or addition of drug content for example). See the sections “FYIs” and “All Other Post Approval Changes”. This industry reviewed document lists the types of changes which would not require review. Given the resemblance to prior APS, we’d do what we can to expedite the process for you. Call a member of our admin team to flag the file accordingly.
